MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Gpi DBS for Dystonia in Pediatric Patients

S. Aydın, H. Canaz (Istanbul, Turkey)

Meeting: 2017 International Congress

Abstract Number: 1192

Keywords: Deep brain stimulation (DBS), Dystonia: Treatment

Session Information

Date: Thursday, June 8, 2017

Session Title: Dystonia

Session Time: 1:15pm-2:45pm

Location: Exhibit Hall C

Objective: Dystonia is a movement disorder in which involuntary sustained or intermittent muscle contractions cause twisting and repetitive movements, abnormal postures, or both. It can be classified as primary or secondary. Pediatric population, however, can also be afflicted by functionally uncapacitating neurological conditions that remain refractory despite the clinicians’ best efforts. In such cases, deep brain stimulation (DBS) offers an alternative treatment.

Background: There is no cure for dystonia and the goal of treatment is to provide a better quality of life for the patient. After DBS surgery, improvement was satisfactory in secondary dystonia group, however, clinical results were better in primary dystonia group.

Methods: From 2012 to the present, we performed DBS for 5 children ( 3 boys and 2 girls) with dystonia. The mean age at the time of treatment was 10,6 ( range 5 – 15 years). Clinical indications for DBS treatment was primary dystonia in 3 patients, secondary dystonia with pantothenate kinase-associated neurodegeneration (PKAN) in 1 patient and secondary dystonia with mitochondrial membrane protein-associated neurodegeneration (MPAN) in 1 patient. All patients had undergone unsuccesful medical treatment for their movement disorder prior to DBS procedure. Bilateral Gpi DBS was performed for all patients. 

Results: No complication occured during or after procedures. After six months, improvement of motor symptoms was seen in all patients. All patients showed significant improvement in their motor symptoms. No DBS related side effects were documented. 

Conclusions: Gpi DBS is a safe and effective treatment for patients with both primary and secondary dystonia and the improvement appears durable.

To cite this abstract in AMA style:

S. Aydın, H. Canaz. Gpi DBS for Dystonia in Pediatric Patients [abstract]. Mov Disord. 2017; 32 (suppl 2). https://www.mdsabstracts.org/abstract/gpi-dbs-for-dystonia-in-pediatric-patients/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/gpi-dbs-for-dystonia-in-pediatric-patients/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley